- Home
- CNTY vs CVM Comparison
CNTY vs CVM Comparison
Compare CNTY & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTY | CVM |
|---|---|---|
| Founded | 1992 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0M | 30.1M |
| IPO Year | 1996 | 1996 |
Fundamental Metrics
Financial Performance| Metric | CNTY | CVM |
|---|---|---|
| Price | $1.28 | $1.55 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | 65.1K | ★ 291.5K |
| Earning Date | 05-08-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.31 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $430,529,000.00 | $264,033.00 |
| Revenue This Year | $7.17 | N/A |
| Revenue Next Year | $3.28 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 10.82 | ★ 65.45 |
| 52 Week Low | $1.14 | $0.89 |
| 52 Week High | $2.85 | $13.48 |
Technical Indicators
Market Signals| Indicator | CNTY | CVM |
|---|---|---|
| Relative Strength Index (RSI) | 56.22 | 60.09 |
| Support Level | $1.24 | $0.95 |
| Resistance Level | $1.35 | $1.59 |
| Average True Range (ATR) | 0.05 | 0.12 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 60.00 | 68.89 |
Price Performance
Historical ComparisonAbout CNTY Century Casinos Inc.
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurants, horse racing (including off-track betting), and entertainment facilities in North America. The company has five reportable segments based on the geographical locations in which its casinos operate; US East, US Midwest, US West, Canada, and Poland.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.